Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

ORPEGEN Pharma

ORPEGEN Pharma is a contract manufacturer for active biopharmaceutical ingredients (bio APIs) such as proteins and peptides using know-how in biotechnological recombinant protein production as well as in peptide chemistry. We are located in Heidelberg, the hot spot of life sciences in Germany.Upon our client's demand it is ORPEGEN Pharma's competence to transform know-how from workbench into process development and further up-scalable GMP production, e.g. by starting from a newly generated cell line for the expression of a protein of medicinal importance or from in-house manufactured amino acid derivatives for the production of pharmaceutical peptides.
These main activities also include contract research & development services in the fields of immunology, protein chemistry, and molecular biology, applied on novel active pharmaceutical ingredients for the drug industry and on the development & production of diagnostics for immunological and haematological indications.


Contact Details:
Czerny-Ring 22
Heidelberg
69115
Germany
Tel:49 6221 9105-0
Fax:49 6221 9105-10
Email:info@orpegen.com
WWW:

www.orpegen.com/




BioNews Results for ORPEGEN Pharma:

Antares Pharma, Inc. - Medical Equipment - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 5:23AM Matching: pharma
Antares Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report
PR inside:  Nov 16 2009 5:23AM Matching: pharma
AspenBio Pharma, Inc. - Medical Equipment - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 4:58AM Matching: pharma
AspenBio Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report
PR inside:  Nov 16 2009 4:46AM Matching: pharma
Bioniche Pharma Acquires Duraclon (clonidine hydrochloride injection) and Methadone Hydrochloride Injection US
Pharma Live:  Nov 15 2009 7:05PM Matching: pharma
Promote your company here: BioNewsCast - Press Release Distribution

View more ORPEGEN Pharma news.

ORPEGEN Pharma Patents:

US Patent No.Title
6835551 Basophil degranulation test
5902733 Test system for determining the activity of natural killer cells

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 381 times since April 2007, the link to the organisation's website has been followed 64 times

Recent Search Terms used to find this page: orpegen pharma | ORPEGEN Pharma | orpegen pharma | Orpegen Pharma | orpegen | orpegen pharma | Orpegen | Orpegen Pharma company profile | Orpegen Pharma | orpegen pharma | .

Search for more companies in Heidelberg

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ORPEGEN Pharma

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.